Related Experiment Videos
[Bone mass and biochemical parameters in metabolic bone diseases]
Y Negoro1, A Tomita, T Masahashi
1Central Laboratory for Clinical Investigation, Aichi Medical University.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 1, 1991
Summary
Bone mineral density (BMD) declines with age in postmenopausal women. Biochemical markers like serum BGP and PTH may help assess metabolic bone diseases, including osteoporosis.
Area of Science:
- Endocrinology
- Bone Metabolism
- Biochemistry
Context:
- Bone mass and its relationship with biochemical parameters are crucial for understanding bone health.
- Age-related bone loss and specific endocrine disorders significantly impact bone mineral density (BMD) and content (BMC).
Purpose:
- To investigate the correlation between bone mass (BMD and BMC) and serum biochemical markers in various patient groups.
- To assess the utility of biochemical parameters in diagnosing metabolic bone diseases.
Summary:
- BMD of the spine and femur negatively correlates with age in postmenopausal women. Osteoporotic postmenopausal women exhibit lower BMD than controls.
- In postmenopausal women, age correlates positively with bone gamma-carboxyglutamate protein (BGP), parathyroid hormone (PTH), and calcitonin (CT).
- Hyperthyroidism and primary hyperparathyroidism are associated with decreased radial BMC, correlating with triiodothyronine (T3) and serum BGP/calcium levels, respectively.
Impact:
- Serum BGP, alkaline phosphatase (ALP), and PTH levels may serve as valuable indicators for assessing metabolic bone diseases.
- This study highlights the interplay between aging, endocrine function, and bone health, informing diagnostic and therapeutic strategies.